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Transcriptomic Analysis of Mouse Embryonic Skin
Cells Reveals Previously Unreported Genes Expressed
in Melanoblasts
Sophie Colombo1,2,3, Delphine Champeval1,2,3, Florian Rambow1,2,3 and Lionel Larue1,2,3
Studying the development of melanoblasts, precursors of melanocytes, is challenging owing to their scarcity
and dispersion in the skin embryo. However, this is an important subject because diverse diseases are
associated with defective melanoblast development. Consequently, characterizing patterns of expression in
melanoblasts during normal development is an important issue. This requires isolating enough melanoblasts
during embryonic development to obtain sufficient RNA to study their transcriptome. ZEG reporter mouse line
crossed with Tyr::Cre mouse line was used to label melanoblasts by enhanced green fluorescent protein (EGFP)
autofluorescence. We isolated melanoblasts by FACS from the skin of E14.5–E16.5 embryos, and obtained
sufficient cells for large-scale transcriptomic analysis after RNA isolation and amplification. We confirmed our
array-based data for various genes of interest by standard quantitative real-time RT-PCR. We demonstrated that
phosphatase and tensin homolog was expressed in melanoblasts but BRN2 was not, although both are involved
in melanomagenesis. We also revealed the potential contribution of genes not previously implicated in any
function in melanocytes or even in neural crest derivatives. Finally, the Schwann cell markers, PLP1 and FABP7,
were significantly expressed in melanoblasts, melanocytes, and melanoma. This study demonstrates the
feasibility of the transcriptomic analysis of purified melanoblasts at different embryonic stages and reveals the
involvement of previously unreported genes in melanoblast development.
Journal of Investigative Dermatology (2012) 132, 170–178; doi:10.1038/jid.2011.252; published online 18 August 2011
INTRODUCTION
Melanoblasts, the precursors of melanocytes, are derived from
neural crest cells during embryonic development. In the mouse
truncal region, founder melanoblasts are determined around
E8.5–E9.5 (Pla et al., 2001; Thomas and Erickson, 2008). From
E10.0 and throughout development, precursor melanoblasts
arising from founder melanoblasts can be visualized as single
cells. From E10.5, the melanoblasts begin to spread from the
migration staging area through the dermis and migrate along a
dorsolateral pathway between the ectoderm and the dorsal
surface of the somites (Wehrle-Haller and Weston, 1995).
Melanoblasts start to cross the basal lamina to enter the
epidermis at E11.5 (Luciani et al. submitted). From E15.5,
melanoblasts either remain at the dermo–epidermal junction or
migrate toward the forming hair follicles.
Mutants obtained by classical or molecular genetic
approaches have various coat color phenotypes, revealing
diverse signaling pathways involved in various steps of the
establishment of the melanocyte lineage, including proliferation,
migration, and differentiation (http://www.espcr.org/micemut/
#cloned). Melanoblast cell lines have been established in
culture to facilitate studies on the differentiation of melano-
cytes. For example, the murine melanoblast Melb-a cell line
grows in culture as non-pigmented; under specific conditions,
Melb-a cells differentiate and produce tyrosinase and melanin
(Sviderskaya et al., 1995). However, these cells were derived
from newborn skin, established in culture on plastic, where
they lost their three-dimensional heterotypic interactions with
keratinocytes (KCs) and were immortalized in culture.
Although very useful, the gene expression pattern of this cell
line is unlikely to reflect fully the gene expression pattern of
melanoblasts in situ at any given embryonic stage.
To investigate the establishment of the melanocyte line-
age, it would be informative to identify the genes involved,
particularly those that are not already implicated. The
discovery of such genes may also help improve our under-
standing of homeostasis and transformation as already
initiated (Loftus et al., 1999). The isolation and molecular
characterization of melanoblasts directly from the embryo at
different stages without affecting their gene expression
patterns would certainly be useful. However, melanoblasts
are difficult to isolate, they do not generate a recognizable
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anatomical structure, and are very scarce. Melanoblasts are
found as single cells interacting with various cells, including
fibroblasts in the dermis and KCs, among others, in the
epidermis. The trunk contains few melanoblasts during
embryonic development: about 7,000 at E14.5 and 18,000
at E15.5 (Delmas et al., 2007).
We report the isolation of E14.5 to E16.5 melanoblasts by
FACS using Tyr::Cre and ZEG mice. We also describe the
gene expression profile of epidermal melanoblasts using
Affymetrix mouse microarrays. We found genes already
involved in melanocyte development, as expected, and we
identified genes not previously known to be expressed in
melanoblasts but that may contribute to the establishment of
the melanocyte lineage.
RESULTS
Isolation of melanoblasts during embryonic development
Tyr::Cre mice expressing the Cre recombinase in melano-
blasts under the control of tyrosinase promoter were crossed
with ZEG mice to label the melanocyte lineage specifically
with enhanced green fluorescent protein (EGFP) (Novak
et al., 2000; Colombo et al., 2010). Before Cre recombina-
tion, ZEG mice produce b-galactosidase in all their cells.
After Tyr::Cre recombination, LacZ gene is deleted and EGFP
production is initiated (EGFPþ LacZ¼GFPþ cells). We
previously reported that the Cre recombinase of the Tyr::Cre
mice defloxed about 90% of the melanoblasts, as estimated
from the percentage of Dct::LacZ-positive cells (Yajima et al.,
2006). The floxed cells, corresponding to non-melanoblast
cells, produce b-galactosidase (EGFP LacZþ ¼GFP
cells). The truncal–dorsal part of E14.5 to E16.5 embryos
was treated with phosphate-buffered saline–EDTA and trypsin
and subjected to dermal–epidermal separation and cell
filtration to obtain melanoblasts as dispersed single cells
(Supplementary Table S1 online). Under a fluorescence
microscope, a heterogenous population of GFPþ (estimated
to be about 1%) and GFP cells was observed (Figure 1a–f).
The cell mixture was FACS sorted (Figure 1g and h). After
FACS analysis, it was estimated that at E14.5 about 0.4%, at
E15.5 0.8%, and at E16.5 1.5% of the cells were obtained
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Figure 1. Dissociation and isolation of melanoblasts. Dissociated cells from Tyr::Cre/1; 1/1 (a–c) and Tyr::Cre/1; ZEG/1 (d–f) epidermis observed under an
inverted fluorescent microscope (Leica, Wetzlar, Germany). Green fluorescent protein (GFP) is observed only in defloxed cells from Tyr::Cre; ZEG/1 embryos
(d–f) and no GFP is observed in non-defloxed cells from Tyr::Cre/1; 1/1 embryos (a–c). FACS dot plots of cells isolated from Tyr::Cre/1; 1/1 (g) and Tyr::Cre/1;
ZEG/1 (h) epidermis. Fluorescence observed on the FITC-A channel shows GFPþ cells only in Tyr::Cre/1; ZEG/1 cell population. SSC-A, side scatter area.
a,b,d,e bar¼ 30 mm.
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as GFPþ . We estimated that we had successfully isolated
20–25% of the melanoblasts present in the skin of E14.5-
E16.5 embryos according to the number of melanoblasts
present in the same region (Delmas et al., 2007).
Quality and size of the RNA isolated from melanoblasts and
cDNA synthesis
Sorted cells were lysed and RNA was extracted. The RNA
quality and quantity were determined. The RNA integrity
number (RIN) ranged from 7.7 (good quality) to 10 (excellent
quality), according to the experiment (Figure 2a and b). The
quality of the RNA was independent of the GFP status of the
cells. From four E14.5 embryos, 6,000 GFPþ cells were
isolated, giving rise to 6 ng of RNA, and from four E16.5
embryos, 40,000 GFPþ cells were isolated, producing 50 ng
of RNA. RNA was reverse-transcribed and amplification was
performed. From each nanogram of RNA, about 5 mg of
amplified cDNA was obtained. The profile of the cDNA
obtained from independent experiments was reproducible,
with most fragments within a size range of 0.2–2 kb (Figure 2c
and d). The quality of the amplification of the RNA was
independent of the GFP status of the cells.
Specificity of cell sorting
The FACS sorting was based on the production of GFP protein
by the cells. From the amplified RNA, we evaluated the
contamination of GFPþ cells by GFP cells and vice versa.
First, the presence of GFP transcripts was evaluated by
standard PCR (Figure 3a). GFP mRNA was only found in
GFPþ cells and not in GFP cells. Second, according to the
ZEG construct, cells that are not able to produce GFP have to
produce LacZ (Novak et al., 2000). LacZ and EGFP mRNA
levels were evaluated by semiquantitative real-time PCR.
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Figure 2. Quality analysis of RNA and amplified cDNA. (a, b) The quality of the RNA was analyzed with the 2100 Bioanalyzer (Agilent) using an RNA 6000
Pico chip. An example of RNA obtained from green fluorescent protein (GFP)þ (a) and GFP (b) cells from one representative experiment at E16.5 is
illustrated. The RIN (RNA integrity number) was generally between 7.7 and 10. (c, d) The quality of the cDNA obtained after reverse transcription and
amplification was also analyzed with the 2100 Bioanalyzer and an RNA 6000 Nano chip. The profiles of the amplified cDNA were, in all cases,
similar, with most fragments being 200 bp to 2 kb long.
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Figure 3. Quality analysis of cell-sorting specificity. (a) The purity of the
green fluorescent protein (GFP)þ and GFP cell populations sorted by FACS
was tested by PCR using amplified cDNA to detect GFP transcripts (499 bp).
One typical experiment at each E15.5 and E16.5 stages is presented. The GFP
mRNA is only present in the GFPþ cell population. The positive and negative
controls were cDNA from total skin of Tyr::Cre/1; ZEG/1; and Tyr::Cre/1; 1/1
mice, respectively. (b) The specificity of sorting was also verified by
semiquantitative real-time PCR with amplified cDNA. One representative
experiment at E16.5 is presented. Mitf-M was expressed only in GFPþ cells,
all of which were melanoblasts, whereas LacZ was only expressed in GFP
cells, which were the non-defloxed cells.
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LacZ mRNA was only found in GFP cells and not in GFPþ
cells (Figure 3b), and EGFP mRNA was only found in
GFPþ cells and not in GFP cells (data not shown). The GFPþ
cells were melanoblasts known to express specific genes
including Mitf-M. We verified that Mitf-M was only produced
in GFPþ cells but not in GFP cells, confirming the high
quality of the FACS sorting procedure (Figure 3b). These various
tests demonstrated that we were able to isolate and study a pure
population of melanoblasts, obtained at a given time, during
embryonic development. The numbers of cells isolated were
sufficient both to evaluate the amounts of mRNA corresponding
to various genes of interest by Q-PCR and to perform a full-
genome microarray analysis.
Expression of PTEN and BRN2 in murine melanoblasts
It is classically accepted that genes involved in transformation
are also involved in the establishment of the associated
lineage during development. We evaluated the expression of
two genes (BRN2 and phosphatase and tensin homolog
(PTEN)) known to be involved in melanomagenesis (Wu
et al., 2003; Goodall et al., 2004), but no information
regarding their expression or their function during embryonic
development of the melanocyte lineage has been reported.
E14.5 to E16.5 melanoblasts were tested for BRN2 mRNA
expression, but none was found (Supplementary Figure S1A
online). With regard to PTEN, we found that it was expressed
in melanoblasts in vivo from E14.5 to E16.5 (Supplementary
Figure S1A online). Consequently, we tested whether PTEN
could have a role in the development of the melanocyte
lineage. Mice carrying a conditional deletion of PTEN in the
melanocyte lineage were produced in the laboratory by
crossing Tyr::Cre with PTENF/F mice (Lesche et al., 2002;
Delmas et al., 2003). On a C57BL/6 background, Tyr::Cre/1,
PTENF/F mice had a coat color phenotype similar to that of
wild-type mice (Supplementary Figure S1B online). Consis-
tent with this observation, we did not observe any difference
in the number of (Tyr::Cre/1; PTENF/F) and (Tyr::Cre/1; PTENþ /þ )
melanoblasts in the truncal part of embryos between E13.5
and E15.5 (Supplementary Figure S1C online). Thus, it seems
that PTEN, although expressed in melanoblasts, does not have
an essential role in the development of these cells during early
embryonic stages.
Gene expression analysis by microarrays
The transcriptomes of E15.5 GFPþ and GFP cells
corresponding, respectively, to melanoblasts and all cells of
the epidermis but melanoblasts (mainly KCs) were compared
for their expression. The ratio of fluorescence intensity
between GFPþ and GFP cells was calculated for each
probe set. Normalized intensity of fluorescence (GFPþ and
GFP) and ratio of fluorescence (GFPþ vs. GFP) data are
given as supplementary data (Supplementary Table S2
online). This identified 50 genes that are highly and
significantly overexpressed in melanoblasts relative to KCs
(Figure 4). These genes were classified according to their
involvement in neural crest cell development and in
melanocytes, including development, homeostasis, melano-
genesis, and melanomagenesis (Supplementary Table S3
online). Some of the 50 genes had not previously been
associated with neural crest cells or melanocytes.
As expected, the genes identified included genes controlling
coat color: Ednrb (endothelin receptor type B—piebald
spotting, which maps on chromosome 14 and is associated
with Hirschsprung’s disease and Waardenburg–Shah syn-
drome), Kit (Kit oncogene—white spotting, located on chromo-
some 5 and associated with piebald syndrome), Pax3 (paired
box gene 3—splotch, chromosome 1 and associated with
Waardenburg syndrome type 1 and 3), Sox10 (SRY-box
containing gene 10—dominant megacolon, chromosome 15
and associated with Waardenburg syndrome type 4), Mitf
(microphthalmia-associated transcription factor—microphth-
almia, chromosome 6 and associated with Waardenburg
syndrome type 2), Tyr (tyrosinase—albino, chromosome 7
and associated with oculocutaneous albinism type 1), Dct
(dopachrome tautomerase—slaty, TRP2, chromosome 14), and
Si (silver, gp100, Pmel-17, chromosome 10). This confirmed the
pertinence of the technique for isolating GFPþ and GFP
cells, these two populations being clearly distinguishable
through their transcriptome.
The products of other genes identified are involved in the
development of neural crest. For instance, Itga4 is involved in
the dorso–lateral migration of neural crest cells, and Ets1 and
Zeb2 in the delamination of neural crest cells. In pigment
cells, Ptgds (a target of Mitf) is involved in the regulation of
melanocyte proliferation and Mlana (Mart1) is involved in
melanogenesis, and these genes were also expressed in
melanoblasts in vivo. Note that Myo7a, an unconventional
myosin that is produced in retinal pigment epithelium and is
involved in melanosome transport, was expressed in skin
melanoblasts.
The genes we identified as markedly expressed in melano-
blasts also included the following genes involved in melano-
magenesis: Dusp4, Ets1, Fabp7, NrCam, Sdcbp (¼Mda9), and
Shc4 (¼RalP). However, these six genes were not previously
known to be involved in embryonic development of the
melanocyte lineage or produced by these embryonic cells.
Finally, many of the genes strongly overexpressed in
melanoblasts compared with KCs had not previously been
implicated in any function in the melanocyte lineage, either
during normal or pathological development. According to a
general PubMed literature search, they include Adm, Ap1s2,
Arnt2, Bace2, Coro2b, Cpeb4, Eif4e3, Elk3, Eya1, GlccI1,
Gpr137b, Lbh, Manba, Mcoln3, Mgll, Mxra7, Plp1, Plxnc1,
Ptgds, Ptprj, Sox11, Ttyh2, Uap1l1, Wdfy1, Zeb2, and
Zfand3, as well as two unknown RIKEN cDNAs. Thus, the
study of the function of these genes in melanocytes may be
informative. It has to be noted that Eya1, Plp1, Sox11, and
Zeb2 are expressed in a sub-population of neural crest cell
derivatives. Preliminary experiments revealed that these 26
genes are expressed at different levels in a panel of four
human melanoma cell lines (Supplementary Figure S2 online).
The murine microarray data were validated on genes
known or unknown to be expressed in melanoblasts (see Mitf
in Figure 3, and data not shown), genes known to be involved
in melanomagenesis (Fabp7 and Shc4), and genes known to
be expressed in neural crest cells (Zeb2, Sox11) and in other
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neural crest cell derivatives (Fabp7 and Plp1). Melb-a, Melan-a,
and B16F10 cells, as well as murine intestine, were used
as controls. Plp1, Fabp7, Shc4, and Zeb2 are expressed in
GFPþ cells, but not in GFP cells, consistent with the
microarray results (Figures 4,5 and Supplementary Table S2
online). Sox11 was weakly expressed in melanoblasts in vivo,
but it was strongly expressed in cultured murine melanocytes
and murine B16 melanoma cells (Figure 5e).
Finally, we specifically assessed the expression of MITF,
DCT, TYR, KIT, SOX10, PAX3, and EDNRB at E14.5, E15.5,
and E16.5 by quantitative real-time RT-PCR on GFPþ and
GFP cells (data not shown). In general, the level of expres-
sion of these genes was similar at E14.5, E15.5, and E16.5.
However, levels of MITF, TYR, and KIT expressed appeared
to be slightly lower at E16.5 than at E15.5 and E14.5.
DISCUSSION
A description of the expression pattern of genes during
melanocyte development would certainly be a valuable
source of information regarding the neural crest cell lineage
and its derivatives, including melanocytes. It would con-
tribute to an improved understanding of these genes in the
melanocyte lineage during homeostasis and melanomagen-
esis, and of various cellular mechanisms such as migration,
proliferation, and differentiation.
The isolation of melanoblasts (Kit-positive CD45-negative
cells) by FACS during development was shown to be feasible
(Kunisada et al., 1996) and this allowed determination of the
level of production of cell–cell adhesion molecules, particu-
larly E-cadherin and P-cadherin (Nishimura et al., 1999).
However, this technique required pooling between 20 and 70
embryos according to the stage. E16.5 melanoblasts have also
been isolated through a genetic GFP-labeling approach using
Dct::Cre and CAG-CAT-EGFP mice (Guyonneau et al., 2004;
Osawa et al., 2005). The first attempt was based on specific
markers, and again required large numbers of embryos. It
allowed a detailed characterization of the expression of
specific genes, but is based on the production of a specific
marker at a certain stage of the life of the cells, and not on the
melanocyte lineage as such.
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Figure 4. Comparative transcriptomic analysis of E15.5 GFPþ and GFP–cells. The cDNAs were fragmented, labeled, and hybridized on whole-mouse genome
arrays (Affymetrix, Santa Clara, CA). (a) The 50 probe sets (each corresponding to one gene) displaying the highest green fluorescent protein (GFP)þ /GFP
ratio of fluorescence intensity are presented. The genes Tyr, Ptgds, Ednrb, and Ap1s2 are present several times because several probe sets corresponding
to these genes displayed a high ratio. Several independent experiments were performed with E15.5 GFPþ and GFP cells and analyzed. (b, c) Scatter plots
showing the intensity of fluorescence of GFPþ cells (from 200 to 800 for b, and 400 to 2,900 for c) versus the intensity of fluorescence of GFP cells are
presented (from 200 to 800 for b, and 400 to 2,900 for c). Note the inset in panel c presenting data for the Dct gene, with an intensity of fluorescence of
134 for GFP cells and of 4,326 for GFPþ cells.
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The approach we develop herein is based on the
melanocyte lineage and appears at least 10 times more
sensitive than those described previously. We isolated high-
quality mRNA from E14.5 to E16.5 melanoblasts suitable for
determining their gene expression profiles. Melanoblasts were
genetically labeled by exploiting the Tyr::Cre and ZEG
transgenic mouse lines that allow specific production of the
autofluorescent EGFP protein in melanoblasts. Once labeled,
melanoblasts were dissociated from embryonic skin and
could be isolated as GFPþ cells either under a fluorescent
microscope or by FACS. This latter procedure was much more
efficient than capillary melanoblast isolation by hand (only
100 GFPþ cells collected per hour). Between 1,500 and
10,000 melanoblasts were recovered by FACS, depending on
the embryonic stage. Moreover, FACS-isolated cells generated
higher quality RNA than hand-isolated cells. This allowed
valuable amplification for gene expression patterning.
Melanoblasts are located either in the dermis or epidermis,
and between E14.5 and E16.5 are mostly present (94 to 99%)
in the epidermis (Luciani et al. submitted). Therefore, the
reported gene expression profile is mainly representative of
epidermal melanoblasts. Moreover, being on a pure genetic
background (C57BL/6), the diversity is reduced, allowing a
better significance of the results or/and a reduction of the
number of required samples.
Although PTEN is expressed in melanoblasts and is a
major tumor suppressor gene involved in melanomagenesis,
the lack of PTEN protein in melanoblasts does not lead to a
coat color phenotype. For the establishment of the melano-
cyte lineage, either PTEN is not required or one or more of the
other 111 characterized phosphatases compensates for it.
Indeed, three PTEN-related genes, PTEN2 (¼ TPTE ), TPIP
(¼ TPTE2), and PLIP (¼ PTPMT1) have been shown to be
redundant with PTEN (Chen et al., 1999; Walker et al., 2001;
Wu et al., 2001; Pagliarini et al., 2004; Easty et al., 2006).
The level of PTEN2 is very low in melanoblasts at E15.5. This
very low level of mRNA is consistent with the very low level
of PTEN2 expression in human melanoma cell lines and
human melanocytes (data not shown). However, PLIP was
significantly expressed in melanoblasts at E15.5, and in
human melanoma cell lines and human melanocytes (data
not shown). This suggests that PLIP may be able to
compensate for the lack of PTEN during establishment of
the melanocyte lineage. Further analysis is required to
address this question specifically.
The gene expression profile of melanoblasts confirmed the
expression of various genes involved in the development of the
melanocyte lineage: Ednrb, Kit, Pax3, Sox10, Mitf, Tyr, Dct,
and Si. It also revealed that some Schwann cell markers (Plp1
and Fabp7) were expressed in melanoblasts; note that
melanocytes and Schwann cells share a common precursor
(Dupin and Le Douarin, 2003). Ernfors and colleagues even
suggested that Schwann cell precursors, expressing Plp1, give
rise to a second wave of melanocytes (Adameyko et al., 2009).
The expression of Plp1 and Fabp7 in E15.5 melanoblasts
certainly suggests that these cells retain some of the precursor
molecular characteristics. The contribution, if any, of these
genes to the establishment of the melanocyte lineage remains
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Figure 5. Quantitative real-time RT-PCR analysis of E15.5 GFPþ and GFP
cells. Semiquantitative real-time PCR was used to assay mRNA in E15.5
GFPþ cells (melanoblasts from three independent experiments) and E15.5
GFP cells (mostly keratinocytes (KCs) from three independent experiments).
Melb-a cells, melan-a cells, B16F10 cells, and adult murine intestine cells
were used as controls. Hypoxanthine-guanine phosphoribosyltransferase
(HPRT) was used as an internal control. (a) PLP1 (b) Fabp7, (c) Zeb2, (d) Shc4,
and (e) Sox11.
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unknown, although they are both involved in melanomagen-
esis; Plp1 belongs to the Hoek melanoma ‘‘proliferative’’
signature (Hoek et al., 2006), and Fabp7 has been implicated
in the progression of melanoma (Slipicevic et al., 2008).
Shc4, also known as RaLP, has been implicated in the
metastatic potential of melanoma by promoting cell migra-
tion (Fagiani et al., 2007). It is possible that Shc4 also has a
role in the migration of melanoblasts during embryonic
development. Ets1 and Zeb2, also known as SIP1, are
negative regulators of E-cadherin (Julien et al., 2007) and
are involved in cell delamination and migration. They are
major factors in epithelial-to-mesenchyme transition (Larue
and Bellacosa, 2005).
Sox proteins (Sox9 and Sox10), members of the same
SRY-related HMG-box gene family, are involved in the
development of the melanocyte lineage. Sox9 regulates the
expression of Sox10 and Mitf-M (Aoki et al., 2003; Passeron
et al., 2007), whereas Sox10 activates the transcription of
Mitf-M and Dct (Potterf et al., 2000). Here, we show that
Sox11 was produced in melanoblasts in vivo. Possibly, this
transcription factor may participate in the regulation of
Mitf-M, Sox10, or/and Dct.
Ingenuity pathway analysis (IPA) was performed on 50
genes (Supplementary Table S4A online). These genes were
selected, for their quality, to be highly expressed in GFPþ
cells compared with GFP cells. From the 50 genes, 40 were
eligible according to IPA (Supplementary Table S4B online).
IPA-based function/disease-related interpretation of the 40
genes revealed different classes including, among others,
Waardenburg’s syndrome, albinism, pigmentation, melanin
biosynthesis, melanoma, as well as migration and differentia-
tion of neural crest cells (Supplementary Table S4C online).
These analyses reflect the fact that the nature of the isolated
cells and associated transcriptome are coherent with our
molecular and cellular knowledge of the melanocyte lineage.
Two significant gene networks were generated (Supple-
mentary Figure S3 online), including some eligible genes
(blue) and IPA-proposed genes (white). The first network may
be split in two parts. The first part includes a large series of
genes associated with Mitf and the second part is mostly
associated with the Map Kinase pathway. The second network
is centered on b-catenin and transforming growth factor-b,
which did not belong to the 50 genes. We may notice that in
both networks the IPA-proposed genes are known to be highly
regulated at the protein level (b-catenin, p38, ERK, and so on),
and the eligible genes are known to be regulated at the RNA
level (Mitf, Sox10, Pax3, Zeb2, and so on).
The in vivo function of some eligible genes in melanoblast
development is not elusive. With appropriate molecular
genetics experiments (including floxed mice for the corre-
sponding genes), it would be relatively easy to conduct such
studies by affecting these genes, specifically in the melano-
cyte lineage in vivo. Mice invalidated for Shc4, Ets1, or Zeb2
may, for example, present a white belly, implicating the
genes in melanoblast migration in vivo. Inactivation of Plp1
and Fabp7 would certainly be informative regarding the
possible bipotency of the melanocyte/Schwann precursor.
The techniques now available make it possible to compare
the gene expression profiles of wild-type and mutant
melanoblasts. Such comparisons will reveal the modifications
associated with the inactivation of any particular gene, and
thereby provide insight into the molecular and cellular
mechanisms involving that gene.
MATERIALS AND METHODS
Transgenic mice
ZEG mice (a gift from Dr C Lobbe, Toronto, Canada), PTEN flox mice
(a gift from Dr Hong Wu, UCLA, Los Angeles, CA), and Tyr::Cre mice
were used (Novak et al., 2000; Lesche et al., 2002; Delmas et al.,
2003). Mice were genotyped using DNA isolated from tail biopsy
specimens with standard PCR conditions. Tyr::Cre, and ZEG
transgenes were detected by PCR as previously described (Colombo
et al., 2007, 2010). All mutant and transgenic mice were backcrossed
more than 10 times with C57BL/6 mice. All animals were housed in
specific pathogen-free conditions in the animal facility at Institut
Curie, in line with French and European Union law. We got the
approval P2.LL.028.07 from the Rene´–Descartes Ethics Committee.
Melanoblast isolation
The fluorescence of (Tyr::Cre/1; 1/1), (1/1; ZEG/1), and (Tyr::Cre/1;
ZEG/1) embryos was evaluated under a Nikon SMZ-U fluorescence
binocular microscope (Nikon Instruments, Melville, NY). Skins from
the trunk of E14.5 to E16.5 embryos were removed with forceps.
Tissues were incubated in phosphate-buffered saline–10mM EDTA at
37 1C for various times according to the embryonic stage (45minutes
at E14.5, 70minutes at E15.5, and 90minutes at E16.5), and then the
dermis was dissociated from the epidermis with forceps (Supple-
mentary Table S1 online). The epidermis from three to six embryos of
the same genotype and same litter were pooled and dissociated in
2.5% Trypsin (10 ) (Invitrogen, Carlsbad, CA) and 0.5mgml1
DNaseI for 10minutes at 37 1C. The reaction was stopped with a
CO2-independent culture medium (Gibco (now Invitrogen), #18045-
088) containing 20% fetal calf serum and 5mM EDTA (pH 8.0). The
cell suspension was passed five times through a 20-G needle to fully
dissociate the epidermal tissue. To minimize the quantity of debris in
suspension, the samples were filtered on a nylon mesh: 30-mm pore-
size filter (MACS, MACS and CliniMACS Products Miltenyi Biotec,
Auburn, CA) for E14.5 and E15.5 cells, and 40 mm filter (Gibco)
followed by a 30-mm (MACS) pore-size filter for E16.5 cells.
Depending on the stage and experiment (pools of three to six
embryos), a total of 8 105 to 6 106 cells was obtained. GFPþ
cells, corresponding to melanoblasts, were separated from GFP
cells, corresponding to other epidermal cells, mainly KCs, with a
FACS Vantage (BD Biosciences, San Jose, CA). For each experiment,
the same numbers of GFPþ and GFP cells were collected (3,000
to 50,000 cells depending on the stage/experiment).
RNA extraction and amplification
Cells were lysed in RLT buffer (Qiagen, Valencia, CA) containing
b-mercaptoethanol (10 ml ml1) and stored at 80 1C. Total RNA was
extracted with the RNAeasy microKit (Qiagen) and eluted in 30 ml
water. RNA quality was analyzed with the 2100 Bioanalyzer
(Agilent, Santa Clara, CA) on RNA 6000 Pico chips to evaluate the
RNA integrity number (as defined at http://www.gene-quantifica-
tion.de/RIN.pdf). RNA (1 ng) was reverse transcribed and amplified
with the WT-Ovation Pico RNA Amplification System (NuGEN, San
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Carlos, CA). A measure of 5–6mg of the resulting cDNA was obtained
for each sample. The amplification quality was verified with the
2100 Bioanalyzer (Agilent) with RNA 6000 Nano chips.
Standard PCR with cDNA
GFP mRNA was analyzed. A 499-bp fragment was amplified with the
forward primer LL1543: 50-acgtaaacggccacaagttc-30 and the reverse
primer LL1544: 50-ggggtgttctgctggtagtg-30. PCR conditions were as
follows: 94 1C for 5minutes, 3 cycles of 94 1C for 1minute, 58 1C for
1minute, 72 1C for 1minute, 25 cycles of 94 1C for 45 seconds, 58 1C
for 30 seconds, 72 1C for 30 seconds, and 72 1C for 10minutes.
Cell lines
The melb-a melanoblast cell line (a gift from Dr D Bennett,
St George’s Hospital Medical School, London, UK), derived from
mouse newborn skin, was cultured in RPMI containing 10% fetal
calf serum, 0.8 ngml1 fibroblast growth factor 2, and 20 ngml1
stem cell factor at 37 1C in a humidified atmosphere with 5% CO2
(Sviderskaya et al., 1995). The melan-a mouse melanocyte cell line
was cultured in F-12 containing 10% fetal calf serum, 2mM
glutamine, 1% penicillin–streptomycin, and 50 nM tissue plasmino-
gen activator and incubated at 37 1C in a humidified atmosphere
with 5% CO2 (Bennett et al., 1989). Murine (B16F10) and human
(MeWo (ATCC #HTB-65, LGC Standards S.a.r.l. 6, Molsheim,
France), WM983B (Corriel Institute # WC00066, Camden, NJ),
SK29 (Moore et al., 2004), and SKmel3 (ATCC # HTB-69)) melanoma
cell lines were cultured in RPMI-1640 containing 10% fetal calf
serum, 2mM glutamine, 100Uml1 penicillin, and 100mgml1
streptomycin and incubated at 37 1C in a humidified atmosphere with
5% CO2. At 80% confluency, cells were collected and total RNA was
extracted using the mRNAeasy mini Kit (Qiagen).
Semiquantitative real-time PCR
Hypoxanthine-guanine phosphoribosyltransferase, Mitf-M, LacZ,
Brn2 (Pou3f2), PTEN, PLP1, Fabp7, Shc4, Zeb2, Sox11 mRNAs
were assayed by semiquantitative real-time PCR. RNA was extracted
from cells in culture and adult mouse intestine tissue with the
mRNAeasy mini Kit (Qiagen) according to the manufacturer’s
instructions, and reverse transcribed using the M-MLV RT system
(Invitrogen). RNA from three independent experiments was pooled
before amplification. Amplified cDNA from GFPþ and GFP cells
obtained from three independent experiments at E14.5, E15.5, and
E16.5 were analyzed.
The reaction was carried out in an iCycler (Bio-Rad, Hercules,
CA). For each sample, 2ml cDNA was used in a reaction volume of
25 ml containing 2 IQ SYBR Green Supermix (Bio-Rad) and 300 nM
primers for hypoxanthine-guanine phosphoribosyltransferase, Mitf-
M, LacZ, Brn2, PLP1, Fabp7, or Zeb2, or 600 nM primers for PTEN,
Shc4, or Sox11. The primers are listed in Supplementary Table S5
online. All samples were analyzed in triplicate. The thermal profile was
95 1C for 1minute 30 seconds and 40 cycles of 95 1C for 30 seconds,
and 60 1C for 1minute. The results reported are standardized to
hypoxanthine-guanine phosphoribosyltransferase gene expression.
5-Bromo-4-chloro-3-indolyl-beta-D-galacto-pyranoside staining
Mice (Tyr::Cre/1 ; PTENF/F) and (Tyr::Cre/1 ; PTENþ /þ ) were crossed
with Dct::LacZ mice (MacKenzie et al., 1997), and the resulting
embryos were collected at various times during pregnancy. Embryos
were stained with 5-bromo-4-chloro-3-indolyl-beta-D-galacto-pyran-
oside, as described previously (Delmas et al., 2003).
Microarrays
RNA isolated from independent preparations of E15.5 GFPþ and
GFP embryonic cells was reverse transcribed. A measure of 5mg of
the resulting cDNA was fragmented and labeled with the FL-Ovation
cDNA Biotin Module V2 Kit (NuGEN). The cDNA was hybridized on
four Mouse Genome 430 2.0 arrays (Affymetrix, Santa Clara, CA)
and the results were normalized with the MAS5 algorithm (http://
www.affymetrix.com/support/technical/whitepapers.affx). Probe sets
with fluorescence intensity inferior to 23.5 were eliminated (back-
ground). A probe set is a group of oligonucleotides fixed on the chip
corresponding to a single gene, a gene being represented by one or
several probe sets. The mean fluorescence intensity for independent
experiments including GFPþ and GFP cells was calculated. Using
the Bayesian approach, applying the moderated t-test, included in
the ‘‘limma’’ package (R), which is adapted to a low number of
samples (n¼ 4), we performed false discovery rate correction by
applying the Benjamini–Hochberg algorithm (accepting 5% false
positive). The lowest corrected P-value for the 50 genes is 0.008 for
LbH and the highest corrected P-value is 0.0002 for MlanA.
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